Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 3/20 | 0.38 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.38 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | ABCB4 | P21439 | 1/20 | 0.38 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.38 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.38 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 3/20 | 0.37 |
| ▸ | PPARA | Q07869 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7174 | 0.93 | ALDH1A1 (0.36) | LPAR1ABCC3ABCC4ABCB11CYP2C8 | |
| SCHEMBL1596 | 0.86 | LPAR1 (0.52) | LPAR1ABCC3ABCC4ABCB11CYP2C8 | |
| SCHEMBL7190 | 0.85 | LPAR1 (0.40) | LPAR1ABCC3ABCC4ABCB11CYP2C8 | |
| SCHEMBL6888 | 0.84 | FFAR1 (0.47) | LPAR1TSHRSMN1; SMN2LPAR2LPAR3 | |
| SCHEMBL7480 | 0.84 | LPAR1 (0.50) | LPAR1ABCC4TSHRBRD4ALDH1A1 | |
| SCHEMBL13720569 | 0.83 | LPAR1 (0.44) | LPAR1ABCC3ABCC4ABCB11CYP2C8 | |
| SCHEMBL12091 | 0.82 | TSHR (0.41) | LPAR1TSHRBRD4ALDH1A1MAPT | |
| SCHEMBL6860 | 0.82 | LPAR1 (0.40) | LPAR1ABCC3ABCC4ABCB11CYP2C8 | |
| SCHEMBL2497 | 0.81 | LPAR1 (0.52) | LPAR1ABCC3ABCC4ABCB11CYP2C8 | |
| SCHEMBL7539 | 0.81 | LPAR1 (0.41) | LPAR1ABCC3ABCC4ABCB11CYP2C8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 50407 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745155-A1 | POWDER CONTAINING PARTICLES OF GELATIN DERIVATIVE AND APPLICATION OF SAME IN MEDICAL TREATMENT | National Institute for Materials Science (JP) | 2026-05-20 | — | — | EP | claimed |
| EP-4741421-A1 | FAB-ARM EXCHANGE-PREVENTING FC VARIANTS FROM WHICH EFFECTOR FUNCTIONS ARE REMOVED | Korea University Research and Business Foundation (KR) | 2026-05-13 | — | — | EP | claimed |
| US-12622973-B2 | Rejuvenation of CAR T cell | PURDUE RESEARCH FOUNDATION (US) | 2026-05-12 | — | — | US | claimed |
| EP-4118431-B1 | INHIBITION OF FKBP1A FOR THE TREATMENT OF TRIPLE-NEGATIVE MAMMARY CARCINOMA | HEINRICH HEINE UNIV DUESSELDORF (DE) | 2026-05-06 | — | — | EP | claimed |
| US-20260117199-A1 | ARTIFICIAL COMPLEX FOR TETHERING CHROMATIDS OR CHROMOSOMES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-04-30 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-12599701-B2 | Drug delivery system and methods of using the same | AXOGEN CORPORATION (US) | 2026-04-14 | — | — | US | claimed |
| EP-4282978-B1 | A UNIVERSAL PLATFORM FOR CAR THERAPY TARGETING A NOVEL ANTIGENIC SIGNATURE OF CANCER | GAVISH GALILEE BIO APPL LTD (IL) | 2026-04-01 | — | — | EP | claimed |
| EP-4713473-A1 | SYSTEM AND METHOD FOR CHECKING THE ABILITY OF A PROTEIN OF INTEREST TO ACT AS A SUBSTRATE FOR AN ENZYME | Julius-Maximilians-Universität Würzburg, in Vertretung des Freistaates Bayern (DE) | 2026-03-25 | — | — | EP | claimed |
| US-12576189-B2 | Nerve grafts containing regenerative compounds, methods of making the same, and methods of treatment using the same | AXOGEN CORPORATION (US) | 2026-03-17 | — | — | US | claimed |
| WO-1993003364-A1 | DETECTION OF IMMUNOSUPPRESSANTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1993-02-18 | — | — | WO | claimed |
| US-5164495-A | ESTERIFICATION, TRIETHYLAMINE | ABBOTT LABORATORIES (US) | 1992-11-17 | — | — | US | claimed |
| WO-1992019745-A1 | RFKBP: A NOVEL PROLYL ISOMERASE AND RAPAMYCIN/FK506 BINDING PROTEIN | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1992-11-12 | — | — | WO | claimed |
| WO-1992008474-A2 | TREATMENT OF LUNG DISEASES | THE NATIONAL HEART & LUNG INSTITUTE (GB) | 1992-05-29 | — | — | WO | claimed |
| WO-1992004055-A1 | IMMUNOSUPPRESSANT COMPOSITION | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1992-03-19 | — | — | WO | claimed |
| WO-1992000739-A1 | 3-PHENYL-5,6-DIHYDROBENZ[C]ACRIDINE-7-CARBOXYLIC ACIDS AND RELATED COMPOUNDS AS IMMUNOSUPPRESIVE AGENTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1992-01-23 | — | — | WO | claimed |
| WO-1991019498-A1 | TREATMENT OF ORGAN TRANSPLANTATION REJECTION | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1991-12-26 | — | — | WO | claimed |
| CN-1056240-A | INHIBITION NF ALLOGRAFT AND CONCORDANT XENOGRAFT REJECTION | IMUTRAN LTD (GB) | 1991-11-20 | — | — | CN | claimed |
| WO-1991004321-A1 | RECEPTOR FOR FK-506 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1991-04-04 | — | — | WO | claimed |
| EP-0401747-A2 | Use of rapamycin and derivatives and prodrugs thereof in the manufacture of a medicament for inhibiting transplant rejection in mammals | Calne, Roy (GB) | 1990-12-12 | — | — | EP | claimed |